Trial Profile
Safety and pharmacokinetics of the subcutaneous Etanercept Biosimilar (Gp2015) administered via an auto-injector or prefilled syringes
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Dec 2016
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Pharmacokinetics
- 27 Oct 2016 Results published in the British Journal of Clinical Pharmacology
- 16 Aug 2016 New trial record